|
1
|
Liang B, Yin JJ and Zhan XR: MiR-301a
promotes cell proliferation by directly targeting TIMP2 in multiple
myeloma. Int J Clin Exp Pathol. 8:9168–9174. 2015.PubMed/NCBI
|
|
2
|
Brigle K and Rogers B: Pathobiology and
diagnosis of multiple myeloma. Semin Oncol Nurs. 33:225–236. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao Q, Luo F, Ma J and Yu X: Bone
metastasis-related Micrornas: New targets for treatment? Curr
Cancer Drug Targets. 15:716–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ribatti D and Vacca A: New insights in
anti-angiogenesis in multiple myeloma. Int J Mol Sci. 19:20312018.
View Article : Google Scholar :
|
|
5
|
D'Ario M, Griffiths-Jones S and Kim M:
Small RNAs: Big impact on plant development. Trends Plant Sci.
22:1056–1068. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Biswas S: MicroRNAs as therapeutic agents:
The future of the battle against cancer. Curr Top Med Chem.
18:2544–2554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Misiewicz-Krzeminska I, Krzeminski P,
Corchete LA, Quwaider D, Rojas EA, Herrero AB and Gutiérrez NC:
Factors regulating microRNA expression and function in multiple
myeloma. Noncoding RNA. 5:92019.
|
|
9
|
Lu J, Liu QH, Wang F, Tan JJ, Deng YQ,
Peng XH, Liu X, Zhang B, Xu X and Li XP: Exosomal miR-9 inhibits
angiogenesis by targeting MDK and regulating PDK/AKT pathway in
nasopharyngeal carcinoma. J Exp Clin Cancer Res. 37:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
11
|
He Y, Li J, Ding N, Wang X, Deng L, Xie Y,
Ying Z, Liu W, Ping L, Zhang C, et al: Combination of enzastaurin
and ibrutinib synergistically induces anti-tumor effects in diffuse
large B cell lymphoma. J Exp Clin Cancer Res. 38:862019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krek A, Grun D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, Piedade ID, Gunsalus KC, Stoffel M and
Rajewsky N: Combinatorial microRNA target predictions. Nat Genet.
37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ritchie W: MicroRNA target prediction.
Methods Mol Biol. 1513:193–200. 2017. View Article : Google Scholar
|
|
14
|
van Iterson M, Bervoets S, de Meijer EJ,
Buermans HP, Hoen PA, Menezes RX and Boer JM: Integrated analysis
of microRNA and mRNA expression: Adding biological significance to
microRNA target predictions. Nucleic Acids Res. 41:e1462013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li M, Linseman DA, Allen MP, Meintzer MK,
Wang X, Laessig T, Wierman ME and Heidenreich KA: Myocyte enhancer
factor 2A and 2D undergo phosphorylation and caspase-mediated
degradation during apoptosis of rat cerebellar granule neurons. J
Neurosci. 21:6544–6552. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Al Masri A, Price-Troska T, Chesi M, Chung
TH, Kim S, Carpten J, Bergsagel PL and Fonseca R: MicroRNA
expression analysis in multiple myeloma. Blood. 106:15542005.
View Article : Google Scholar
|
|
17
|
Zhao Y, Xie Z, Lin J and Liu P: MiR-144-3p
inhibits cell proliferation and induces apoptosis in multiple
myeloma by targeting c-Met. Am J Transl Res. 9:2437–2446.
2017.PubMed/NCBI
|
|
18
|
Tianhua Y, Dianqiu L, Xuanhe Z, Zhe Z and
Dongmei G: Long non-coding RNA Sox2 overlapping transcript (SOX2OT)
promotes multiple myeloma progression via microRNA-143-3p/c-MET
axis. J Cell Mol Med. 24:5185–5194. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Raimondi L, Amodio N, Di Martino MT,
Altomare E, Leotta M, Caracciolo D, Gullà A, Neri A, Taverna S,
D'Aquila P, et al: Targeting of multiple myeloma-related
angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor
activity. Oncotarget. 5:3039–3054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Estrella NL, Desjardins CA, Nocco SE,
Clark AL, Maksimenko Y and Naya FJ: MEF2 transcription factors
regulate distinct gene programs in mammalian skeletal muscle
differentiation. J Biol Chem. 290:1256–1268. 2015. View Article : Google Scholar :
|
|
21
|
Ewen EP, Snyder CM, Wilson M, Desjardins D
and Naya FJ: The Mef2A transcription factor coordinately regulates
a costamere gene program in cardiac muscle. J Biol Chem.
286:29644–29653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ribatti D, Nico B, Crivellato E, Roccaro
AM and Vacca A: The history of the angiogenic switch concept.
Leukemia. 21:44–52. 2007. View Article : Google Scholar
|
|
23
|
Roccaro AM, Sacco A, Thompson B, Leleu X,
Azab AK, Azab F, Runnels J, Jia X, Ngo HT, Melhem MR, et al:
MicroRNAs 15a and 16 regulate tumor proliferation in multiple
myeloma. Blood. 113:6669–6680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van de Donk NW, Lokhorst HM, Nijhuis EH,
Kamphuis MM and Bloem AC: Geranylgeranylated proteins are involved
in the regulation of myeloma cell growth. Clin Cancer Res.
11:429–439. 2005.PubMed/NCBI
|
|
25
|
Gupta N, Kumar R, Seth T, Garg B and
Sharma A: Targeting of stromal versican by miR-144/199 inhibits
multiple myeloma by downregulating FAK/STAT3 signalling. RNA Biol.
17:98–111. 2020. View Article : Google Scholar
|
